Overexpression of miR-135b attenuates pathological cardiac hypertrophy by targeting CACNA1C
Tài liệu tham khảo
Osterholt, 2013, Alterations in mitochondrial function in cardiac hypertrophy and heart failure, Heart Fail. Rev., 18, 645, 10.1007/s10741-012-9346-7
Liu, 2014, Cardiac hypertrophy is negatively regulated by miR-541, Cell Death Dis., 5, e1171, 10.1038/cddis.2014.141
Berk, 2007, ECM remodeling in hypertensive heart disease, J. Clin. Invest., 117, 568, 10.1172/JCI31044
Dong, 2010, Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy, Hypertension, 55, 946, 10.1161/HYPERTENSIONAHA.109.139519
Weeks, 2011, The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes?, Physiology (Bethesda), 26, 97
Lee, 2003, The nuclear RNase III Drosha initiates microRNA processing, Nature, 425, 415, 10.1038/nature01957
Farh, 2005, The widespread impact of mammalian MicroRNAs on mRNA repression and evolution, Science, 310, 1817, 10.1126/science.1121158
Yang, 2007, The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2, Nat. Med., 13, 486, 10.1038/nm1569
Callis, 2008, Taking microRNAs to heart, Trends Mol. Med., 14, 254, 10.1016/j.molmed.2008.03.006
Xiang, 2015, MicroRNA135b regulates the stability of PTEN and promotes glycolysis by targeting USP13 in human colorectal cancers, Oncol. Rep., 33, 1342, 10.3892/or.2014.3694
Issler, 2014, MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity, Neuron, 83, 344, 10.1016/j.neuron.2014.05.042
Su, 2016, miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1, Biomed Pharmacother, 84, 123, 10.1016/j.biopha.2016.09.027
Xu, 2014, MicroRNA-135b promotes proliferation, invasion and migration of osteosarcoma cells by degrading myocardin, Int. J. Oncol., 45, 2024, 10.3892/ijo.2014.2641
Honardoost, 2015, Expression change of miR-214 and miR-135 during muscle differentiation, Cell J., 17, 461
Xie, 2017, Suppression of microRNA-135b-5p protects against myocardial ischemia/reperfusion injury by activating JAK2/STAT3 signaling pathway in mice during sevoflurane anesthesia, Biosci. Rep., 37, 10.1042/BSR20170186
Kalsotra, 2014, The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression, Cell Rep., 6, 336, 10.1016/j.celrep.2013.12.025
Gillis, 2012, Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: expanding the spectrum of Timothy syndrome, Am. J. Med. Genet. A, 158A, 182, 10.1002/ajmg.a.34355
Burashnikov, 2010, Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death, Heart Rhythm., 7, 1872, 10.1016/j.hrthm.2010.08.026
Muth, 2001, Ca(2+)-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha, Circulation, 103, 140, 10.1161/01.CIR.103.1.140
Huang, 2002, Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium-channel-dependent, Mol. Cell. Biochem., 231, 51, 10.1023/A:1014432923220
Chen, 2011, Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy, J. Mol. Cell. Cardiol., 50, 460, 10.1016/j.yjmcc.2010.11.012
Shyu, 2005, Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart, J. Biomed. Sci., 12, 409, 10.1007/s11373-005-3008-x
Zhang, 2013, MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma, Cancer Lett., 331, 230, 10.1016/j.canlet.2013.01.003
Sun, 2008, RNAi inhibition of phosphodiesterase 1A prevents cold-induced hypertension and cardiac hypertrophy, Circulation, S285
Jordan, 2002, Cyclosporin A regulates sodium-calcium exchanger (NCX1) gene expression in vitro and cardiac hypertrophy in NCX1 transgenic mice, Ann. N. Y. Acad. Sci., 976, 259, 10.1111/j.1749-6632.2002.tb04748.x
